Effect of gonadotropin-releasing hormone in long-term controlled internal drug-release protocols on pregnancy rates in beef heifers artificially inseminated after observed estrus or fixed time

2013 ◽  
Vol 29 (3) ◽  
pp. 228-236
Author(s):  
R.K. Peel ◽  
J.L. Seabrook ◽  
G.E. Seidel ◽  
J.C. Whittier ◽  
A.V. Grove ◽  
...  
Keyword(s):  
Drug Release ◽  
Fixed Time ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Beef Heifers ◽  
Releasing Hormone

7 PREGNANCY RATES IN BEEF HEIFERS SYNCHRONIZED WITH A SHORTENED OESTRADIOL-BASED TREATMENT THAT PROVIDES FOR A PROLONGED PROESTRUS

2015 ◽  
Vol 27 (1) ◽  
pp. 96 ◽  
Author(s):  
A. Menchaca ◽  
R. Nuñez-Olivera ◽  
F. Cuadro ◽  
G. Bo
Keyword(s):  
Treatment Group ◽  
Day Treatment ◽  
Fixed Time ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Device Removal ◽  
Beef Heifers ◽  
Releasing Hormone ◽  
Secondary Objective ◽  
To Receive

An oestradiol-based protocol (named J-Synch) has been developed recently with the aim of providing for a longer proestrus, enhancing the development of the dominant follicle before ovulation, and increasing pregnancy rates following fixed-time AI (FTAI) in heifers (de la Matta and Bo 2012 Taurus 55, 17–23). Two experiments were performed in Uruguay with 1953 Angus × Hereford crossbred heifers to compare pregnancy rates obtained with the J-Synch protocol with the conventional 7-day oestradiol-based protocol. A secondary objective was to determine the effects of the time of FTAI and the addition of eCG at the time progestin device removal on pregnancy rates. In Experiment 1, 966 heifers received a DIB device (0.5 g of progesterone, Syntex, Buenos Aires, Argentina) plus 2 mg of oestradiol benzoate IM (Syntex) on Day 0. Heifers in the conventional treatment group (n = 485) received cloprostenol (500 μg, Ciclase DL, Syntex) and oestradiol cypionate (0.5 mg, Cipiosyn, Syntex) IM and had their DIB removed on Day 7 a.m. Heifers in this group were then subdivided to be FTAI on Day 9 a.m. or p.m. (i.e. 48 or 56 h after DIB removal). Heifers in the J-Synch treatment group (n = 481) received cloprostenol IM and DIB removal on Day 6 p.m. and received gonadotropin-releasing hormone (100 μg gonadorelin acetate, Gonasyn Gdr, Syntex) on Day 9 a.m.; heifers were then FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). All heifers in this experiment were also treated with 300 IU of eCG (Novormon, Syntex) at DIB removal. In Experiment 2, 987 heifers were treated with the J-Synch protocol as described in Experiment 1. At device removal (Day 6 p.m.), heifers were divided to receive (n = 488) or not (n = 499) 300 IU of eCG IM at that time and were further subdivided to receive gonadotropin-releasing hormone and FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). Pregnancy rates were determined by ultrasonography 30 days after FTAI. Data were analysed using logistic regression, and results are shown in Table 1. J-Synch-treated heifers tended (P < 0.1) to have higher pregnancy rates following FTAI, whereas time of FTAI only affected pregnancy rates following the conventional 7-day treatment (P < 0.05). However, removal of eCG from the J-Synch protocol in Experiment 2 resulted in reduced pregnancy rates when inseminations were done on Day 9 p.m. (P < 0.05). In summary, the addition of eCG to the J-Synch protocol provided for a wider window of insemination times facilitating FTAI in large groups of beef heifers. Table 1.Effect of length of progestin insertion, time of insemination and eCG treatment on pregnancy rates in beef heifers

Estrous synchronization and fertility of cross-bred dairy cows using prostaglandin F2α and gonadotropin releasing hormone

2021 ◽  
pp. 171-175
Author(s):  
Abubakr O. Ismail ◽  
◽  
Erneo B. Ochi ◽  
Ambrose S. Jubara ◽  
Bakri Ahmed A/Rahim ◽  
...  
Keyword(s):  
Dairy Cows ◽  
Artificial Insemination ◽  
Prostaglandin F2α ◽  
Fixed Time ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Releasing Hormone ◽  
Treatment Groups ◽  
Estrous Synchronization ◽  
Descriptive Statistical Analysis

A comparative hormonal study of prostaglandin, gonadotropin releasing hormone and their combination was conducted on 30 randomly selected cross-bred dairy cows of SEMEX project for artificial insemination in Hillat Kuku, Khartoum North, Sudan. The study attempts to determine the response of the animals to hormonal induction and synchronization of estrous as well as fertility following fixed time artificial insemination. Three treatment groups of 10 cows each were undertaken. Groups 1, 2 and 3 involved administration of prostaglandin F2α (PGF2α), gonadotropin releasing hormone (GnRH) and a combination of PGF2α + GnRH, respectively. Descriptive statistical analysis was performed. The results revealed that all the three protocols induced and synchronized estrous were almost synchronous in all the treated groups. However, protocol 3 revealed a significantly (p<0.05) better result of 70% pregnancy rate compared to other two protocols that equally provided 50% pregnancy rates. The study resolves that protocol 3 be highly recommended to change the mindset of farmers about the spread of reproductive technology in Sudan. Protocols 1 and 2 provided acceptable pregnancy rates that can be enhanced with the improvement of management.

104 FACTORS AFFECTING PREGNANCY RATES AND EMBRYO/FETAL LOSSES IN RECIPIENTS RECEIVING IN VITRO-PRODUCED EMBRYOS BY FIXED-TIME EMBRYO TRANSFER

2017 ◽  
Vol 29 (1) ◽  
pp. 160
Author(s):  
A. Tribulo ◽  
A. Cedeño ◽  
B. Bernal ◽  
S. Andrada ◽  
J. L. Barajas ◽  
...  
Keyword(s):  
Embryo Transfer ◽  
Body Condition Score ◽  
Prostaglandin F2α ◽  
Fixed Time ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Device Removal ◽  
Releasing Hormone ◽  
Condition Score

A retrospective analysis evaluated pregnancy rates and embryo losses with in vitro-produced embryos in a commercial embryo transfer program on 15 different beef farms. Recipients were beef cows and heifers (n = 1841) that were synchronized with 5 different protocols and transferred at a fixed-time (FTET). Recipients were examined by ultrasonography on Day 0, and those with a corpus luteum (CL) or a follicle ≥8 mm in diameter and with body condition score 2 to 4 (1 to 5 scale) were synchronized. The synchronization treatments were as follows. (T1) Recipients received an intravaginal device with 0.5 g of progesterone plus 2 mg of oestradiol benzoate on Day 0; device removal, plus 500 μg of cloprostenol (prostaglandin F2α), 400 IU of eCG, and 0.5 mg of oestradiol cypionate on Day 8; and FTET on Day 17. (T2) This treatment was similar to T1 but 1 mg of oestradiol cypionate was injected at device removal instead of 0.5 mg of oestradiol cypionate. (T3) This treatment was similar to T1 except that animals were tail-painted on Day 8 and observed on Day 10. Those with the tail-paint intact on Day 10 received 100 μg of gonadorelin (gonadotropin-releasing hormone) and all recipients were FTET on Day 17. (T4) Recipients received a progesterone device on Day 0; device removal, prostaglandin F2α, and eCG on Day 5; gonadotropin-releasing hormone on Day 8; and FTET on Day 15. (T5) Recipients received a progesterone device and 2 mg of oestradiol benzoate on Day 0; device removal, prostaglandin F2α, and eCG on Day 6; gonadotropin-releasing hormone on Day 9; and FTET on Day 16. On the day of FTET all recipients with CL ≥18 mm in diameter (G1), ≥16 and <18 mm in diameter (G2), and ≥14 mm and <16 mm in diameter (G3) received in vitro-produced fresh embryos. Pregnancy was diagnosed by ultrasonography at 30 and 60 days of gestation, and data were analysed by logistic regression. The overall proportion of recipients synchronized that were FTET was 80.8% (1487/1841), with a 30-day pregnancy rate to FTET (P/FTET) of 45.6% (678/1487) and the rate of 30- to 60-day embryo/fetal loses on the 528 recipients that were re-checked at 60 days was 12.8% (68/528). There were no significant differences in P/FTET among operators, animal category, time of the year, embryo stage, or body condition score; however, there was a significant effect of farm (P < 0.001) and CL diameter (P < 0.05), but no interaction between CL diameter and farm or treatment (P > 0.1). Recipients with G1 (443/953, 46%) and G2 (221/462, 47%) CL had higher pregnancy rates than those with G3 CL (23/71, 32%). There was a significant effect of synchronization treatment on the proportion of recipients transferred and on P/FTET (P < 0.01) that was highly influenced by farm (farm by treatment interaction P < 0.01). The proportions of recipients selected for embryo transfer were as follows: T1: 386/486, 79.4%; T2: 233/331, 70.3%; T3: 342/377, 90.7%; T4: 126/160, 78.7%; and T5: 400/487, 82.1%. The P/FTET were as follows: T1: 190/386, 49.2%; T2: 96/233, 41.2%; T3: 175/342, 51.1%; T4: 49/126, 38.8%; and T5: 168/400, 42.0%. Although 30- to 60-day embryo/fetal losses were not influenced by synchronization treatments, they were highly influenced by farm (P < 0.001) and ranged from 0 to 34.5%. In conclusion, P/FTET in a commercial program with beef in vitro-produced embryos was influenced by factors related to the recipient (CL diameter) and the environment (farm), whereas embryo/fetal losses were influenced by farm but not treatment or recipient factors.

scholarly journals Effect of GnRH and D-Chloprostenol application on pregnancy and prolificacy rates on Pelibuey ewes

2013 ◽  
pp. 3612-3617 ◽  
Author(s):  
Jaime Martínez T ◽  
Oziel Montañez V ◽  
Alejandro Ley De C ◽  
Fernando Izaguirre F ◽  
María Velazco Z ◽  
...  
Keyword(s):  
Chorionic Gonadotropin ◽  
Medroxyprogesterone Acetate ◽  
Fixed Time ◽  
Average Concentration ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Ovarian Activity ◽  
Releasing Hormone ◽  
Natural Mating ◽  
Equine Chorionic Gonadotropin

ABSTRACTObjective. Was to evaluate the effect of GnRH and D-Chloprostenol application on pregnancy and prolificacy rates on Pelibuey ewes. Materials and methods. Forty five ewes were randomly allocated to one of three treatments: T1(n=15), day 0: sponges with 65 mg medroxyprogesterone acetate (MPA) + 200 IU equine chorionic gonadotropin (eCG) and sponge removal (day 12) + breeding by natural mating (days 12-15); T2 (n=15), day 0: 50 μg gonadotropin releasing hormone (GnRH) + 7.5 mg D-Chloprostenol (day 5) + 50 μg GnRH (day 7) + insemination at fixed time (AIFT) 12 to 14 h after last injection of GnRH; T3 (n=15), 100 μg GnRH (day 0) + 7.5 mg D-Chloprostenol (day 5) + 100 μg GnRH (day 7) + AIFT 12 to 14 h after last injection of GnRH. Results. The average concentration of progesterone (P4) in blood was 1.22 ± 0.74 ng/mL, which was used to verify ovarian activity at the beginning of the treatments. 100% of the T1 ewes presented estrus, beginning at 38.4±9.56 h after sponge removal. There were differences (p<0.05) for pregnancy rates, of 60, 33.33 and 46.66% respectively, among the treatments. Prolificacy was no different (p>0.05) among the treatments where the values were 1.2, 1.4 and 1.4 lambs/ewe for T1, T2 and T3, Conclusions. The results of this study show that the use of GnRH and D-Chloprostenol did improve pregnancy rates but did not improve prolificacy in tropical ewes

scholarly journals Evaluation of the 7 and 7 synch protocol for control of the estrous cycle among beef cows prior to fixed-time artificial insemination with sex-sorted or conventional semen

2021 ◽  
Author(s):  
◽  
Carson M. Andersen
Keyword(s):  
Artificial Insemination ◽  
Fixed Time ◽  
Beef Cows ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Releasing Hormone ◽  
Prostaglandin F2 Alpha ◽  
Estrus Detection ◽  
To Receive ◽  
Activation Status

Experiment 1 was conducted to compare 7 and 7 Synch and the 7-day CO-Synch + controlled internal drug release (CIDR[copyright]) protocols prior to fixed-time artificial insemination (FTAI) of beef cows with conventional or sex-sorted semen. Cows (n = 1,538) were blocked based on age and days postpartum (DPP) and randomly assigned to protocol and semen type. Cows assigned to 7-day CO-Synch + CIDR (n = 769) received administration of gonadotropin-releasing hormone (GnRH) and insertion of an intravaginal progesterone-releasing insert (CIDR) on Day -10, and administration of prostaglandin F2[alpha] (PG) coincident with CIDR removal on Day -3. Cows assigned to 7 and 7 Synch (n = 769) received PG and insertion of CIDR on Day -17, GnRH on Day -10, and PG coincident with CIDR removal on Day -3. Estrus detection aids were applied to all cows. Cows received FTAI 66 h after CIDR removal with conventional (20 x 106 cells per unit) or sex-sorted (4 x 106 cells per unit) semen. Estrus expression was affected by protocol (P = 0.01) by protocol x DPP (P = 0.0004), with 7 and 7 Synch (82 percent; 629/769) resulting in a greater proportion of cows expressing estrus (82 percent [629/769] versus 64 percent [492/769]), especially among cows with greater DPP. Pregnancy rates to FTAI were reduced (P < 0.0001) when using sex-sorted semen but greater among cows treated with 7 and 7 Synch (conventional semen: 72 percent [280/389]; sex-sorted semen: 52 percent [199/380]) compared with 7-day CO-Synch + CIDR (conventional semen: 61 percent [233/383]; sex-sorted semen: 44 percent [171/386]). Experiment 2 was designed to evaluate later timing of fixed-time artificial insemination (FTAI) with sex-sorted semen among postpartum beef cows following the 7 and 7 Synch protocol, with the hypothesis that later timing would result in increased pregnancy rates (P/AI) among cows that expressed estrus prior to FTAI. Beef cows (n=414) were blocked based on age and days postpartum (DPP) and randomly assigned to receive FTAI at 66 or 72 h after administration of prostaglandin F2[alpha] (PG). Estrus was synchrized using the 7 and 7 Synch protocol, which consists of administration of PG (500 [mu]g cloprostenol) and insertion of an intravaginal progesterone-releasing insert (CIDR; 1.38 g progesterone) on Day 0, gonadotropin-releasing hormone (GnRH; 100 [mu]g gonadorelin) on Day 7, and PG coincident with CIDR removal on Day 14. Estrus detection aids (EstrotectTM) were applied to all cows on Day 14, and activation status was recorded at fixed-time artificial insemination (FTAI) on Day 17. All cows that expressed estrus prior to FTAI received sex-sorted semen (4 x 106 cells per unit; SexedULTRA 4MTM). The proportion of cows expressing estrus prior to FTAI did not differ between treatments at this power of test (66 h: 71 percent [146/205]; 72 h: 76 percent [158/209]). Additionally, P/AI of estrous cows inseminated with sex-sorted semen did not differ between treatments (66 h: 45 percent [68/146]; 72 h: 40 percent [63/158]). In conclusion, later timing of FTAI following the 7 and 7 Synch protocol failed to improve P/AI of estrous cows inseminated h sex-sorted semen.

103 INFLUENCE OF ESTRUS EXPRESSION AND TREATMENT WITH GONADOTROPIN-RELEASING HORMONE ON PREGNANCY RATES IN RECIPIENTS SYNCHRONIZED WITH PROGESTERONE DEVICES AND ESTRADIOL AND TRANSFERRED AT A FIXED TIME

2017 ◽  
Vol 29 (1) ◽  
pp. 159 ◽  
Author(s):  
A. Cedeño ◽  
A. Tribulo ◽  
S. Andrada ◽  
J. L. Barajas ◽  
J. Fonseca ◽  
...  
Keyword(s):  
Embryo Transfer ◽  
Buenos Aires ◽  
Body Condition Score ◽  
Fixed Time ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Releasing Hormone ◽  
Condition Score

An experiment was designed to evaluate whether expression of oestrus in recipients synchronized with progesterone devices and oestradiol affects pregnancy rates to a fixed-time embryo transfer (FTET). A secondary objective was to determine whether administration of gonadotropin-releasing hormone (GnRH) to those recipients not showing oestrus by 48 h after device removal had an effect on pregnancy rates. Mature, non-lactating beef recipients (Bonsmara, Brangus, and Braford; n = 729), with a corpus luteum (CL) or a follicle ≥8 mm in diameter detected by ultrasonography (Mindray DP 30, Shenzhen, China) and body condition score 2 to 4 (1 to 5 scale) were synchronized in 7 replicates. On Day 0, recipients received a progesterone device (DIB 0.5 g, Zoetis, Buenos Aires, Argentina) and 2 mg of oestradiol benzoate (Gonadiol, Zoetis). On Day 8, DIB were removed and recipients received 400 IU eCG (Novormon 5000, Zoetis) plus 0.5 mg of oestradiol cypionate (Cipiosyn, Zoetis) and 500 μg of cloprostenol (Cyclase, Zoetis). In addition, all cows were tail-painted on the sacrococcygeal area (CeloTest, Biotay, Buenos Aires, Argentina) at DIB removal and were observed to determine the expression of oestrus, according to the percentage of paint loss 48 h later. The animals that showed oestrus (paint loss >30%) were recorded, and those with paint loss ≤30% (not in oestrus) were randomly allocated to receive 100 μg of gonadorelin (GnRH; Gonasyn, Zoetis) or no treatment. On Day 17, all recipients were examined by ultrasonography and those with a CL ≥18 mm (G1), ≥16 and <18 mm (G2), or ≥14 and <16 mm (G3) in diameter received in vivo-produced frozen-thawed embryos by direct transfer or fresh in vitro-produced embryos. Pregnancy was diagnosed by ultrasonography at 23 days after FTET, and data were analysed by logistic regression. There were no differences between replicates, in vivo- and in vitro-produced embryos, or operators (P > 0.2). However, the proportion of recipients transferred and pregnant (P/FTET) was higher (P < 0.05) for those that showed oestrus at 48 h after DIB removal (422/454, 93.0% and 227/471, 48.2%) than those that did not show oestrus (109/211, 51.7% and 45/120, 37.5%). Within the recipients not showing oestrus, P/FTET was significantly higher (P < 0.05) in those that received GnRH (34/74, 45.9%) than in those that did not receive GnRH (12/46, 26.1%). There was a significant interaction (P < 0.05) between CL diameter and expression of oestrus. When recipients had CL ≥18 mm in diameter (G1), P/FTET did not differ (oestrus: 164/338, 48.5% v. no oestrus 30/65, 46.2%); however, when CL diameter was <18 mm and ≥14 mm (G2 and G3), P/FTET was higher (P < 0.05) in those that showed oestrus (37/85, 43.5%) than in those that did not show oestrus (11/43, 25.6%). Finally, P/FTET was higher (P < 0.05) in recipients with a CL (268/573, 46.8%) on Day 0 than in those with follicles >8 mm in diameter (4/18, 22.2%). In conclusion, the expression of oestrus significantly affected the percentage of recipients selected for embryo transfer and P/FTET. Furthermore, treatment of recipients not showing oestrus by 48 h after DIB removal with GnRH at that time increased P/FTET.

Sign in / Sign up

Export Citation Format

Share Document